The future of the global GMP cell therapy consumables market looks promising with opportunities in the clinical, commercial, and research markets. The global GMP cell therapy consumables market is expected to reach an estimated $63.4 billion by 2030 with a CAGR of 28.1% from 2024 to 2030. The major drivers for this market are increasing demand for cell therapy, increasing demand for regenerative medicines, and rise in demand for personalized medicine.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the GMP cell therapy
consumables market by type (kits, reagents/molecular biology reagents, growth
factors/cytokines and interleukins, and others), cell therapy (NK cell therapy,
stem cell therapy, t-cell therapy, and others), process (sorting & separation,
cell culture & preparation, cryopreservation, cell processing &
formulation, cell isolation & activation, cell distribution, process
monitoring & control, and others), end use (clinical, commercial, research,
and others), and region (North America, Europe, Asia Pacific, and the Rest of
the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, NK cell
therapy, stem cell therapy, and t-cell therapy are the major segments of GMP
cell therapy consumables market by cell therapy. Lucintel forecasts that stem
cell therapy is expected to witness highest growth over the forecast period
because it has a potential to treat different diseases, including cancer,
neurodegenerative diseases, and cardiovascular diseases.
Within this market,
clinical will remain the largest segment due to increasing number of cell
therapy clinical trials underway globally.
North America is
expected to witness highest growth over the forecast period due to high demand
for cell therapy, strong government support for cell therapy research and
development, and presence of a large number of cell therapy companies.
Sartorius, Thermo Fisher
Scientific, Miltenyi Biotec Bv, Bio-Techne, Corning, Fujifilm Irvine
Scientific, and Lonza are the major suppliers in the GMP cell therapy
consumables market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment